Ultragenyx Pharmaceutical  logo
Ultragenyx Pharmaceutical RARE
$ 47.18 2.52%

Quarterly report 2024-Q3
added 11-16-2024

report update icon

Ultragenyx Pharmaceutical EV/EBITDA Ratio 2011-2024 | RARE

Annual EV/EBITDA Ratio Ultragenyx Pharmaceutical

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-16.2 -24.3 -6.2 -6.59 -6.92 -10.3 -13.5 -29.4 - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-6.2 -29.4 -14.2